Skip to main content
. 2020 Mar 20;34(3):327–348. doi: 10.1007/s40259-020-00417-y

Table 2.

Comparison of different cell-free systems reported in the literature with their significant properties

Cell-free system origin Strengths Weaknesses Protein examples
Prokaryotic
Escherichia coli

CF lysates are simple to prepare and very efficient

CFPS is simple with a high yield of proteins within a few hours (depends on protein)

Suitable for establishment in large scale in many research laboratories and companies

Cost effective and doesn’t need a large infrastructure

Highly stable and receptive to external supplements

Lysates used for point-of-care testing [30, 31]

Wealth of genetic tools and literature

No PTMs

Not suitable for MPs and proteins whose folding function depend on PTMs

Lack of translationally active endogenous microsomes

Need to supply additional membrane solubilization supplements for MPs

Larger proteins (> 70 kDa) prone to higher aggregation or truncated products [47]

Contamination with endotoxins

Trimeric influenza hemagglutinin stem domain (6-h batch): 400 μg/mL [48]

NavSp1p (2-h batch): 20 μg/mL [49]

PfFNT (CECF overnight): 4 mg/mL [50]

TDH (2-h batch): 300 μg/mL [51]

Kv 1.3 (4-h batch): 15–25 μg/mL [52]

hVDAC1: 10 mg/mL [53]

Streptomyces

Suitable for GC-rich proteins [34]

Simple and robust preparation of lysates

No PTMs reported

No endogenous microsomes

EGFP (3-h batch): 50 µg/mL and (48-h CECF): 282 µg/mL [34]

Tbr (P,Q,N,I) and TEII (3-h batch): 11–17 µg/mL [34]

Bacillus subtilis

Alternative to the E. coli-based system

Wealth of genetic tools and literature

No PTMs

Lack of translationally active endogenous microsomes

Relatively very new and limited reports

GFP (2.5-h batch): 22 µg/mL [32]

Luciferase (1-h batch): 40–150 μg/mL [54]

Vibrio natrigens

Generate a high volume of the active lysate (8–12 mL/1 L culture) [12]

Robust lysate preparation and high metabolic efficiency

Highly stable at room temperature for 1 wk

Higher ribosomal concentration per cell compared with E. coli

Limited applications until now

Relatively very new

Opistoporin 1: 278 µg/mL [12]

Cecropin A: 22 µg/mL [12]

Cecropin P1: 96.8 µg/mL [12]

EGFP: 400 µg/mL [55]

Eukaryotic
Insect Spodoptera frugiperda 21 (Sf21)

Mimic the Sf21 cell-based production

PTMs (N-glycosylation, disulfide bridging, and lipidation)

Suitable for a wide range of eukaryotic and complex proteins

Presence of translationally active endogenous microsomes [14]

High yields in CECF mode

Endotoxin free

Low yields especially in the batch mode

Cost ineffective and difficult to establish unlike E. coli-based system

KcSA (4 h batch): 8 µg/mL [56]

hEGFR (2-h batch): 6 µg/mL [14]

(3 × 2-h batch [repetitive]): 15 µg/mL [14]

(24-h CECF): 285 µg/mL [57]

Chinese hamster ovary (CHO)

Mimic the CHO cell-based production

PTMs (N-glycosylation, disulfide bridging, and lipidation)

Suitable for a wide range of eukaryotic and complex proteins

Presence of translational active endogenous microsomes [45]

High yields in CECF mode

Endotoxin free

Lysates used for point-of-care testing [30]

Low yields especially in the batch mode [58]

Cost ineffective and difficult to establish unlike E. coli-based system

Streptokinase (CECF): 500 µg/mL [59]

Human TLR9 receptor [18]

(3-h batch): 21 µg/mL

(48-h CECF): 900 µg/mL

hEGFR [46]

(batch): 40 µg/mL

(CECF): 800 µg/mL

Wheat germ

No codon optimization necessary

Highly efficient translation machinery, suitable for a wide variety of proteins including MPs and eukaryotic proteins that do not depend on PTMs for their functionality [47]

Alternative to E. coli-based system for producing high yield of proteins

Highly stable and resistant to external supplements

Promising system for vaccine development

No endogenous mRNA

Lack of endogenous microsomes

Need to supply additional solubilization supplements for MPs

CF lysate preparation is time consuming

Lack of glycosylation

GFP (3-h batch): 1.6 mg/mL [43]

hTERT (48-h CECF): 1.5 mg/mL [58]

HRH1 (24-h CECF): 800 µg/mL [60]

Tobacco BY-2

Very fast lysate preparation (4–5 h)

Presence of endogenous microsomes allowing PTMs (glycosylation and disulfide bond)

High translational efficiency

Relatively undeveloped

PTMs not well characterized

Vitronectin-specific full-size human antibody M12 (18-h batch): 150 µg/mL [35]

Heparin-binding EGF-like growth factor (HbEGF) (18-h batch): 25 µg/mL [35]

Glucose oxidase: 7.34 U/mL [35]

hCNTF (16-h batch): 20 µg/mL [58, 61]

Cultured human cells (HeLa, K562 extracts)

Mimic the human cell-based production

PTMs (N-glycosylation, disulfide bridging, and lipidation)

Suitable for a wide range of eukaryotic and complex proteins [47]

Presence of translationally active endogenous microsomes

Endotoxin free

Low yields and not well established

Cost ineffective and difficult to establish unlike E. coli-based system

Luciferase (2-h batch): 21 µg/mL [62]

GST (CECF HeLa): 50 µg/mL [63]

hCNTF (6-h batch): 50 µg/mL [61]

Rabbit reticulocyte

Cap-independent translation

PTMs

Suitable for large complex proteins [64]

Easy to prepare

Low translation efficiency

Difficult to prepare lysates

Need to externally supply exogenous microsomes for protein folding

Ethical issues

nAChR: no data [44]

HBc: no data [65]

EGFP (batch): 30 µg/mL [66]

FhSAP2 (1.5-h batch): 500 µg/mL [67]

Leishmania tarentolae

Lowest aggregation propensity

Better solubility of expressed proteins

Background translation of endogenous mRNA suppressed

Ease of handling similar to E. coli and offer complete eukaryotic expression

Protein synthesis only reported for GFP

Not so well established

No PTMs reported

EGFP (batch): 300 µg/mL [66]

NPT4 (16-h CECF): 50 µg/mL [68]

Neurospora Rapid and inexpensive

No report of endogenous microsomes

No report of PTMs established

Luciferase (30-min batch): 2.5 µg/mL [37]
Saccharomyces cerevisiae

Easy to prepare

Wealth of genetic tools available and cell culture literature

Contains eukaryotic folding machinery

Lack of endotoxins

No PTMs reported

Low batch yields

CF system underdeveloped

HPV 58 L1 (3-h batch): 60 µg/mL [69]

CAT (5-h batch): 10 µg/mL [38]

EPO (6-h CECF): 40 µg/mL [70]

CAT chloramphenicol acetyl transferase, CECF continuous exchange cell-free synthesis, CF cell-free, CFPS cell-free protein synthesis, E. coli Escherichia coli, EGFP enhanced green fluorescent protein, EPO human erythropoietin, FhSAP2 Fasciola hepatica saposin-like protein-2, GC guanine-cytosine, GFP green fluorescent protein, GST glutathione S-transferase, HBc hepatitis B-core protein, hCNTF human ciliary neurotrophic factor, hEGFR human epidermal growth factor receptor, HPV 58 human papillomavirus-58, HRH1 human histamine H1 Receptor, hTERT human telomerase reverse transcriptase, hVDAC1 human voltage dependent anionic channel, KcSA pH-gated potassium channel, Kv1.3 voltage gated potassium channel, MPs membrane proteins, NavSp1p Silicibacter pomeroyi voltage-gated sodium channel, nAChR nicotinic acetylcholine receptor, NPT4 human sodium phosphate transporter 4, PfFNT plasmodium lactate transporter, PTM post-translational modification, TDH thermostable direct hemolysin, Tbr (P,Q,N,I) genes involved in the biosynthesis of peptide tambromycin, TEII type II thioesterase, TLR9 toll-like receptor 9